Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 5—May 2016
Research

Expanded Geographic Distribution and Clinical Characteristics of Ehrlichia ewingii Infections, United States

Rebecca M. Harris1, Brianne A. Couturier, Stephan C. Sample, Katrina S. Coulter, Kathleen K. Casey, and Robert SchlabergComments to Author 
Author affiliations: Author affiliations: University of Utah School of Medicine, Salt Lake City, Utah, USA (R.M. Harris, R. Schlaberg); Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology, Salt Lake City (B.A. Couturier, R. Schlaberg); Memorial Hospital and Healthcare Center, Jasper, Indiana, USA (S.C. Sample); University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (K.S. Coulter); Jersey Shore University Medical Center, Neptune, New Jersey, USA (K.K. Casey)

Main Article

Table 2

Results for patients tested for infection with Ehrlichia and Anaplasma species by real-time PCR, United States

State* No. tested No. (%) positive
E. chaffeensis E. canis/ewingii A. phagocytophilum
Arkansas 3 0 (0) 1 (33.3) 0 (0)
Colorado 3 1 (33.3) 0 (0) 0 (0)
Connecticut 23 0 (0) 0 (0) 3 (13)
Georgia 7 1 (14.2) 0 (0) 0 (0)
Illinois 70 4 (5.7) 0 (0) 0 (0)
Indiana 263 25 (9.5) 3 (1.1) 0 (0)
Iowa 4 1 (25) 0 (0) 0 (0)
Kansas 52 10 (19.2) 0 (0) 0 (0)
Kentucky 26 8 (30.8) 0 (0) 0 (0)
Louisiana 11 1 (9.1) 0 (0) 0 (0)
Maine 375 0 (0) 0 (0) 17 (4.5)
Massachusetts 526 0 (0) 0 (0) 40 (7.6)
Michigan 3 1 (33.3) 0 (0) 0 (0)
Minnesota 930 0 (0) 0 (0) 44 (4.7)
Missouri 94 15 (15.9) 4 (4.3) 0 (0)
Nebraska 69 8 (11.6) 0 (0) 1 (1.4)
New Hampshire 708 1 (0.1) 0 (0) 51 (7.2)
New Jersey 202 7 (3.5) 1 (0.5) 5 (2.5)
New York 283 3 (1.1) 1 (0.4) 6 (2.1)
Pennsylvania 72 2 (2.8) 0 (0) 1 (1.4)
Tennessee 150 6 (4) 0 (0) 0 (0)
Texas 52 2 (3.8) 0 (0) 1 (1.9)
Utah 16 1 (6.3) 0 (0) 0 (0)
Virginia 28 0 (0) 0 (0) 1 (3.6)
Washington 24 2 (8.3) 0 (0) 0 (0)
Wisconsin 68 0 (0) 0 (0) 9 (13.2)

*States for which all patents showed negative results are Alabama (n = 2), Arizona (n = 11), California (n = 19), Florida (n = 9), Hawaii (n = 1), Idaho (n = 1), Montana (n = 1), Nevada (n = 3), North Carolina (n = 6), North Dakota (n = 2), Ohio (n = 25), Oregon (n = 8), Rhode Island (n = 3), South Dakota (n = 21), and Wyoming (n = 3).

Main Article

1Current affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external